These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 11931626)

  • 61. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening.
    Giordanetto F; Kull B; Dellsén A
    Bioorg Med Chem Lett; 2011 Jan; 21(2):829-35. PubMed ID: 21169017
    [TBL] [Abstract][Full Text] [Related]  

  • 63. vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available.
    Chaput L; Martinez-Sanz J; Quiniou E; Rigolet P; Saettel N; Mouawad L
    J Cheminform; 2016; 8():1. PubMed ID: 26807156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Aggregation Advisor for Ligand Discovery.
    Irwin JJ; Duan D; Torosyan H; Doak AK; Ziebart KT; Sterling T; Tumanian G; Shoichet BK
    J Med Chem; 2015 Sep; 58(17):7076-87. PubMed ID: 26295373
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.
    Bachovchin DA; Brown SJ; Rosen H; Cravatt BF
    Nat Biotechnol; 2009 Apr; 27(4):387-94. PubMed ID: 19329999
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study.
    Ghattas MA; Al Rawashdeh S; Atatreh N; Bryce RA
    J Chem Inf Model; 2020 Aug; 60(8):3901-3909. PubMed ID: 32628846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aggregating behavior of phenolic compounds--a source of false bioassay results?
    Pohjala L; Tammela P
    Molecules; 2012 Sep; 17(9):10774-90. PubMed ID: 22960870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
    Tomohara K; Adachi I; Horino Y; Kesamaru H; Abe H; Suyama K; Nose T
    ACS Med Chem Lett; 2019 Jun; 10(6):923-928. PubMed ID: 31223449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of non-substrate-like glycosyltransferase inhibitors from library screening: pitfalls & hits.
    Ema M; Xu Y; Gehrke S; Wagner GK
    Medchemcomm; 2018 Jan; 9(1):131-137. PubMed ID: 30108907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Small-molecule inhibitors of the Rce1p CaaX protease.
    Manandhar SP; Hildebrandt ER; Schmidt WK
    J Biomol Screen; 2007 Oct; 12(7):983-93. PubMed ID: 17942791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A structure-guided computational screening approach for predicting plant enzyme-metabolite interactions.
    Holland CK; Tadfie H
    Methods Enzymol; 2022; 676():71-101. PubMed ID: 36280362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.
    Kwarcinski FE; Steffey ME; Fox CC; Soellner MB
    ACS Med Chem Lett; 2015 Aug; 6(8):898-901. PubMed ID: 26286460
    [TBL] [Abstract][Full Text] [Related]  

  • 73. From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules.
    Kaoud TS; Yan C; Mitra S; Tseng CC; Jose J; Taliaferro JM; Tuohetahuntila M; Devkota A; Sammons R; Park J; Park H; Shi Y; Hong J; Ren P; Dalby KN
    ACS Med Chem Lett; 2012 Aug; 3(9):721-725. PubMed ID: 23002419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MO-MEMES: A method for accelerating virtual screening using multi-objective Bayesian optimization.
    Mehta S; Goel M; Priyakumar UD
    Front Med (Lausanne); 2022; 9():916481. PubMed ID: 36213671
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Method for Identifying Small-Molecule Aggregators Using Photonic Crystal Biosensor Microplates.
    Chan LL; Lidstone EA; Finch KE; Heeres JT; Hergenrother PJ; Cunningham BT
    JALA Charlottesv Va; 2009 Dec; 14(6):348-359. PubMed ID: 20930952
    [TBL] [Abstract][Full Text] [Related]  

  • 76. De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive Hits.
    Ng S; Juang YC; Chandramohan A; Kaan HYK; Sadruddin A; Yuen TY; Ferrer-Gago FJ; Lee XC; Liew X; Johannes CW; Brown CJ; Kannan S; Aronica PG; Berglund NA; Verma CS; Liu L; Stoeck A; Sawyer TK; Partridge AW; Lane DP
    ACS Med Chem Lett; 2020 Oct; 11(10):1993-2001. PubMed ID: 33062184
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.
    Garner AL; Lorenz DA; Sandoval J; Gallagher EE; Kerk SA; Kaur T; Menon A
    ACS Med Chem Lett; 2019 May; 10(5):816-821. PubMed ID: 31098005
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Techniques for Screening Translation Inhibitors.
    Osterman IA; Bogdanov AA; Dontsova OA; Sergiev PV
    Antibiotics (Basel); 2016 Jun; 5(3):. PubMed ID: 27348012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Can children be promiscuous?
    Hanks A
    Can Fam Physician; 1983 May; 29():870. PubMed ID: 21283364
    [No Abstract]   [Full Text] [Related]  

  • 80. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
    Seidler J; McGovern SL; Doman TN; Shoichet BK
    J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.